Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Is MediPharm Labs’ CFO the CEO it needs? Why Greg Hunter’s interim role could reshape the company MediPharm Labs names Greg Hunter interim CEO. Find out what this leadership change means for execution, strategy, and investor sentiment. byPallavi MadhirajuJanuary 19, 2026